Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage

Lung Cancer

Volumn 78, Issue 3, 2012, Pages 234-238

  Collaud, Stéphane ^a   Stahel, Rolf ^a   Inci, Ilhan ^a   Hillinger, Sven ^a   Schneiter, Didier ^a   Kestenholz, Peter ^a   Weder, Walter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Adrenals; Brain; Lung; Lung cancer; Metastatic; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

ADRENAL METASTASIS; ADRENALECTOMY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LUNG SUBLOBAR RESECTION; LUNG SURGERY; MALE; MULTIPLE CYCLE TREATMENT; NEUROSURGERY; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THORACOTOMY; TUMOR LOCALIZATION; WHOLE BRAIN RADIATION THERAPY;

ADULT; AGED; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 84868300148     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.09.011     Document Type: Article

References (19)

1. Quint L.E., Tummala S., Brisson L.J., Francis I.R., Krupnick A.S., Kazerooni E.A., et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg 1996, 62:246-250.
2. Groome P.A., Bolejack V., Crowley J.J., Kennedy C., Krasnik M., Sobin L.H., et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:694-705.
3. Pfannschmidt J., Dienemann H. Surgical treatment of oligometastatic non-small cell lung cancer. Lung Cancer 2010, 69:251-258.
4. Luketich J.D., Martini N., Ginsberg R.J., Rigberg D., Burt M.E. Successful treatment of solitary extracranial metastases from non-small cell lung cancer. Ann Thorac Surg 1995, 60:1609-1611.
5. Billing P.S., Miller D.L., Allen M.S., Deschamps C., Trastek V.F., Pairolero P.C. Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg 2001, 122:548-553.
6. Saitoh Y., Fujisawa T., Shiba M., Yoshida S., Sekine Y., Baba M., et al. Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer. Lung Cancer 1999, 24:99-106.
7. Wronski M., Arbit E., Burt M., Galicich J.H. Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. J Neurosurg 1995, 83:605-616.
8. Beitler A.L., Urschel J.D., Velagapudi S.R., Takita H. Surgical management of adrenal metastases from lung cancer. J Surg Oncol 1998, 69:54-57.
9. Luketich J.D., Burt M.E. Does resection of adrenal metastases from non-small cell lung cancer improve survival?. Ann Thorac Surg 1996, 62:1614-1616.
10. Sobin L.H., Wittekind C. TNM classification of malignant tumours 2002, John Wiley and Sons, New York. 6th ed.
11. Lardinois D., De Leyn P., Van Schil P., Porta R.R., Waller D., Passlick B., et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006, 30:787-792.
12. Bonnette P., Puyo P., Gabriel C., Giudicelli R., Regnard J.F., Riquet M., et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest 2001, 119:1469-1475.
13. Furak J., Trojan I., Szoke T., Agocs L., Csekeo A., Kas J., et al. Lung cancer and its operable brain metastasis: survival rate and staging problems. Ann Thorac Surg 2005, 79:241-247. discussion 241-247.
14. Mussi A., Pistolesi M., Lucchi M., Janni A., Chella A., Parenti G., et al. Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors. J Thorac Cardiovasc Surg 1996, 112:146-153.
15. Tanvetyanon T., Robinson L.A., Schell M.J., Strong V.E., Kapoor R., Coit D.G., et al. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol 2008, 26:1142-1147.
16. Voltolini L., Rapicetta C., Luzzi L., Ghiribelli C., Paladini P., Granato F., et al. Surgical treatment of synchronous multiple lung cancer located in a different lobe or lung: high survival in node-negative subgroup. Eur J Cardiothorac Surg 2010, 37:1198-1204.
17. Iwasaki A., Shirakusa T., Yoshinaga Y., Enatsu S., Yamamoto M. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor. Eur J Cardiothorac Surg 2004, 26:488-493.
18. Nakagawa T., Okumura N., Miyoshi K., Matsuoka T., Kameyama K. Prognostic factors in patients with ipsilateral pulmonary metastasis from non-small cell lung cancer. Eur J Cardiothorac Surg 2005, 28:635-639.
19. Downey R.J., Ng K.K., Kris M.G., Bains M.S., Miller V.A., Heelan R., et al. A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis. Lung Cancer 2002, 38:193-197.